¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï¾Æ»êº´¿ø Á¦10ȸ ¾Æ»ê¾È°ú ½ÉÆ÷Áö¾ö-Â÷Èï¿ø,À±¿µÈñ ±³¼ö´Ô Á¤³âÅðÀÓ±â³ä : 2023-02-05

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼­¿ï¾Æ»êº´¿ø Á¦10ȸ ¾Æ»ê¾È°ú ½ÉÆ÷Áö¾ö-Â÷Èï¿ø,À±¿µÈñ ±³¼ö´Ô Á¤³âÅðÀÓ±â³ä : 2023-02-05
±³À°ÀÏÀÚ : 2023-02-05
±³À°Àå¼Ò : µ¿°ü 6Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : Á¦10ȸ ¾Æ»ê¾È°ú ½ÉÆ÷Áö¾ö-Â÷Èï¿ø,À±¿µÈñ ±³¼ö´Ô Á¤³âÅðÀÓ±â³ä
ÁÖÃÖ±â°ü : ¼­¿ï¾Æ»êº´¿ø
´ã´çÀÚ : ÇÔÇý¿ø
¿¬¶ôó : 02-3010-6130  
À̸ÞÀÏ : yewonham@amc.seoul.kr      
±³À°Á¾·ù : ¾È°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 3ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 08:20~08:28 Retina as a window for neurodegenerative diseases  ¾ÈÁöÀ±(¼­¿ï´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 08:28~08:36 Genetic testing in inherited retinal dystrophy  ±èÀ±Àü(¿ï»ê´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 08:36~08:44 Gene Therapy for inherited retinal dystrophy  º¯¼®È£(¿¬¼¼´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 08:44~08:52 Extracellular Vesicle (EV): Emerging Therapeutic Opportunities for Retinal Diseases  Sun Young Lee(University of Southern California) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 08:52~09:00 Biophysical and molecular profiling of exosomes in retinal diseases  ÀÌÁØ¿±(¿ï»ê´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 09:00~09:08 Molecular diagnosis of primary vitreoretinal lymphoma  À̽±Ô(¿¬¼¼´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 09:08~09:16 Management of complications in intraocular tumors  ±è¹Î(¿¬¼¼´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 09:16~09:24 Exploring the role of interleukin in retinal and uveal diseases  ¼ÛÁöÈÆ(¾ÆÁÖ´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 09:24~09:32 Biosimilars in ophthalmology  ¿ì¼¼ÁØ(¼­¿ï´ë) 
È޽Ġ02-05 µ¿°ü ´ë°­´ç 09:32~09:45 Coffee break  () 
±âŸ 02-05 µ¿°ü ´ë°­´ç 09:45~09:55 Ceremony  () 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 09:55~10:25 Retinal implants for Vision Restoration  Mark S. Humayun(University of Southern California) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 10:25~10:45 Plenary lecture: Diabetic choroid and retina  À±¿µÈñ(¿ï»ê´ë) 
È޽Ġ02-05 µ¿°ü ´ë°­´ç 10:45~11:00 Coffee break & Photo time  () 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:00~11:08 Epiretinal membrane and metamorphopsia  ¼ÕÁØÈ«(Çѱæ¾È°úº´¿ø) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:08~11:16 Imaging analysis for progression and predicting prognosis of idiopathic epiretinal membrane  º¯Àͼö(ºÎ»ê´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:16~11:24 Surgical treatment of Epiretinal membrane  ¹Ú±ÔÇü(¼­¿ï´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:24~11:32 The Significance of Epiretinal Tissue (LHEP) in Full Thickness Macular Hole  °­¼¼¿õ(¼º±Õ°ü´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:32~11:40 Diagnosis and managements of myopic macuopathy  ±èÀ¯Ã¶(°è¸í´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:40~11:48 Prevention of atrophic age related macular degeneration  À¯Çü°ï(ÇϴþȰú) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:48~11:56 Issues to be considered in pachychoroid neovasculopathy  ÀÌ¿ø±â(´©³×¾È°úº´¿ø) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 11:56~12:04 Hyper-and hypo-perfusion of choriocapillaris in pachychoroid pigment epitheliopathy  ±èÁöÅÃ(Áß¾Ó´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 12:04~12:12 Choroidal angioarchitecture in various retinal diseases  ¹Ú¿µÈÆ(°¡Å縯´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 12:12~12:20 Cell therapy strategies for neovascular AMD  ÀÌÁÖ¿ë(¿ï»ê´ë) 
½Ä»ç 02-05 µ¿°ü ´ë°­´ç 12:20~13:10 Lunch  () 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 13:10~13:18 Dry eye: what on earth is Dry eye syndrome?  ¼­°æ·ü(¿¬¼¼´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 13:18~13:26 Microbiome and Ocular surface disease  ±è¹Ì±Ý(¼­¿ï´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 13:26~13:34 The Future of Dry Eye Treatment: from the view of current dry eye treatment  À±°æö(Àü³²´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 13:34~13:42 Deep dive into MGD and its treatment  ¼ÛÁ¾¼®(°í·Á´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 13:42~13:50 Exosome treatment for Dry eye disease  ±èÈ«±Õ(°æºÏ´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 13:50~13:58 Conjunctivomullerectomy for Superior Limbic Keratoconjunctivitis with Ptosis  ¹ÚÁøÇü(¹Ì¼ÒEYE¾È°ú) 
Åä·Ð 02-05 µ¿°ü ´ë°­´ç 13:58~14:08 Discussion  () 
±âŸ 02-05 µ¿°ü ´ë°­´ç 14:08~14:18 Ceremony  () 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 14:18~14:48 Toward Corneal Regenerative Medicine  Shigeru Kinoshita(Kyoto Prefectural University of Medicine) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 14:48~15:08 Plenary lecture: My clinical experience in Asan Medical Center  Â÷Èï¿ø(¿ï»ê´ë) 
Åä·Ð 02-05 µ¿°ü ´ë°­´ç 15:08~15:18 Discussion  () 
È޽Ġ02-05 µ¿°ü ´ë°­´ç 15:18~15:38 Coffee break & Photo time  () 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 15:38~15:48 Cataract surgery: tips for best cataract surgeon  À̵µÇü(ÀÎÁ¦´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 15:45~15:54 Happy situation after Multifocal IOL Implantation with ABC  ±è¸íÁØ(¸®´º¼­¿ï¾È°ú) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 15:54~16:02 Mastering toric IOLs: astigmatism correction  À¯ÀÎõ(ÀüºÏ´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 16:02~16:10 Introduction of Novel Medical Device for the treatment of dry eye disease after refractive surgery  Á¤Å¿µ(¼º±Õ°ü´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 16:10~16:18 Phakic IOL: Leave it or not  Á¤¼ÒÇâ(°¡Å縯´ë) 
Åä·Ð 02-05 µ¿°ü ´ë°­´ç 16:18~16:28 Discussion  () 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 16:28~16:36 DSAEK: Key Steps to Get Started with DSAEK  ±èÀç¿ë(¿ï»ê´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 16:36~16:44 DMEK: For beginners just like Me !!  ÀÌÈÆ(¿ï»ê´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 16:44~16:52 Perfect option for conjunctivochalasia treatment  ÃÖö¿µ(¼º±Õ°ü´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 16:52~17:00 New treatment technique for Recurrent corneal erosion  °íº´ÀÌ(°Ç¾ç´ë) 
±³À°½Ã°£ 02-05 µ¿°ü ´ë°­´ç 17:00~17:08 What Can I do with Amniotic membrane: Corneal perforation  Á¤ÁøÈ£(Á¦ÁÖ´ë) 
Åä·Ð 02-05 µ¿°ü ´ë°­´ç 17:08~17:18 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼­¿ï¾Æ»êº´¿ø Á¦10ȸ ¾Æ»ê¾È°ú ½ÉÆ÷Áö¾ö-Â÷Èï¿ø,À±¿µÈñ ±³¼ö´Ô Á¤³âÅðÀÓ±â³ä : 2023-02-05""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽºÆ÷Ã÷ÀÇÇÐȸ 2023 ÆÀÇÇÁö¼Ç ¿¬¼ö°­Á : 2023-02-05
´ÙÀ½±Û ÇØ¿î´ë¹éº´¿ø Á¦44ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ ¿öÅ©¼¥ : 2023-02-04
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
210 ¼­¿ï 2018³â ¼­¿ï¾Æ»êº´¿ø ¾Ïº´¿ø ½ÉÆ÷Áö¾ö : 2018-09-07 0 540 2018-07-28
209 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ 2018³â ¹Î°£¡¤°ø°øÇù·Â(PPM) ±¹°¡°áÇÙ°ü¸®»ç¾÷ Æò°¡´ëȸ : 2018-09-07 0 612 2018-07-28
208 ´ë±¸ ±¹¸³ÀÇ·á¿ø °ø°øÀÇ·á Consensus conference(4Â÷: °æ»óÁ¦ÁÖ±Ç) : 2018-09-07 0 623 2018-07-28
207 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-09-07 0 327 2018-07-28
206 ¼­¿ï °í·Á´ëÇб³¾È¾Ïº´¿ø ÀÏÂ÷ ÀÇ·áÁø°ú ÇÔ²²ÇÏ´Â ½É¹æ¼¼µ¿ÀÇ Ä¡·á : 2018-09-07 0 550 2018-07-28
205 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] ÀÇ·á»ç°í¿Í Á¶Á¤ ÁßÀç / ¼³¸íÀǹ« : 2018-09-06 0 413 2018-07-28
204 ¼­¿ï 2018³âµµ ´ëÇѺñ¸¸ÇÐȸ ±¹Á¦Çмú´ëȸ(ICOMES 2018) - 09/06 : 2018-09-06 0 377 2018-07-28
203 ¼­¿ï ±¹¸³ÀÇ·á¿ø 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-09-06 0 540 2018-07-28
202 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø 2018 ¾à¹°ÀÌ»ó¹ÝÀÀ ½ÉÆ÷Áö¾ö : 2018-09-05 0 959 2018-07-28
201 ¼­¿ï ±¹¸³ÀÇ·á¿ø 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-09-05 0 649 2018-07-28
200 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø »ç½Ã Áø·áÀÇ ÇÔÁ¤À» ÇÇÇØ°¡·Á¸é : 2018-09-04 0 1,077 2018-07-28
199 ¼­¿ï Á¦ÀϺ´¿ø 2018 »ý½Ä¹ß»ýµ¶¼º¿¬±¸ ¹× ¸¶´õ¸®½ºÅ©ÇÁ·Î±×·¥ÀÇ ÃֽŰæÇâ : 2018-09-02 0 688 2018-07-28
198 ±¤ÁÖ 2018 Àü³²´ëÇб³º´¿ø ½ÅÀå³»°ú ¿¬¼ö°­Á : 2018-09-02 0 928 2018-07-28
197 ¼­¿ï ´ëÇѺñ¸¸°Ç°­ÇÐȸ 2018 Ãß°èÇмú´ëȸ : 2018-09-02 0 981 2018-07-28
196 ¼­¿ï Á¦3ȸ °æÈñ´ëÇб³º´¿ø ¿°Áõ¼ºÀåÁúȯ¼¾ÅÍ °³¿øÀÇ ¿¬¼ö°­Á -¿°Áõ¼ºÀåÁúȯ Áø·áÀÇ ÃֽŠµ¿Çâ - : 2018-09-02 0 1,508 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷